Innovator Company v. Canada (Attorney General), 2017 FC 864

JurisdictionFederal Jurisdiction (Canada)
Subject MatterPRACTICE,COURTS,ADMINISTRATIVE LAW
Citation2017 FC 864
CourtFederal Court (Canada)
Date26 September 2017
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
6 practice notes
  • Table of Cases
    • Canada
    • Irwin Books The Regulation of Drugs in Canada. The Food and Drugs act and Related Intellectual Property Regimes - 2024 Part II
    • December 22, 2023
    ...290, 295, 298, 300, 306 Innovator Company v Canada (Attorney General), 2017 FC 548 , af’d 2017 FC 864 ...............................................................220 Janssen Inc v Canada (Attorney General), 2020 FC 904 , af‘d 2021 FCA 137 ...................................................
  • The Patented Medicines (Notice of Compliance) Regulations
    • Canada
    • Irwin Books The Regulation of Drugs in Canada. The Food and Drugs act and Related Intellectual Property Regimes - 2024 Part II
    • December 22, 2023
    ...of the PM(NOC) Regulations do not apply to its submission; see Innovator Company v Canada (Attorney General) , 2017 FC 548, af’d 2017 FC 864, and cases cited therein. 84 Merck & Co, Inc v Canada (Attorney General) , 2000 CanLII 15094 (FCA). 85 Above note 6. 86 AstraZeneca v Canada , above n......
  • Open Court Principle Means No Secret Proceedings If They Would Directly Affect A Competitor's Rights
    • Canada
    • Mondaq Canada
    • November 9, 2017
    ...the manufacturer to provide its competitor with information about the proceeding. Case Innovator Company v Canada (Attorney General), 2017 FC 864 [Innovator IP Type Patents Summary In Innovator Company, a pharmaceutical manufacturer ("Innovator") filed a submission for regulatory approval o......
  • Open Court Principle Means No Secret Proceedings If They Would Directly Affect a Competitor's Rights
    • Canada
    • JD Supra Canada
    • October 2, 2017
    ...the manufacturer to provide its competitor with information about the proceeding. Case Innovator Company v Canada (Attorney General), 2017 FC 864 [Innovator IP Type Patents Summary In Innovator Company, a pharmaceutical manufacturer (“Innovator”) filed a submission for regulatory approval o......
  • Request a trial to view additional results
4 firm's commentaries

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT